Select Previous Investments

< back to select previous investments

Serenex

Durham, NC

Serenex was an oncology-focused drug development company using its novel chemoproteomics technology to accelerate the discovery of high value therapeutics for important human diseases. Serenex was acquired by Pfizer in April 2008

Acquired by Pfizer